Glenmark pharmaceuticals ltd. – product pipeline review – 2012


Published on

2012 | Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012

Published in: Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Glenmark pharmaceuticals ltd. – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Glenmark Pharmaceuticals Ltd. – Product Pipeline Review –2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s pharmaceuticals report, “Glenmark Pharmaceuticals Ltd. -Product Pipeline Review - 2012” provides data on the Glenmark PharmaceuticalsLtd.’s research and development focus. The report includes information on currentdevelopmental pipeline, complete with latest updates, and features on discontinuedand dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Glenmark Pharmaceuticals Ltd.’s corporate website, SECfilings, investor presentations and featured press releases, both from GlenmarkPharmaceuticals Ltd. and industry-specific third party sources, put together byGlobal Markets Direct’s team.Scope- Glenmark Pharmaceuticals Ltd. - Brief Glenmark Pharmaceuticals Ltd. overviewincluding business description, key information and facts, and its locations andsubsidiaries.- Review of current pipeline of Glenmark Pharmaceuticals Ltd. human therapeuticdivision.- Overview of pipeline therapeutics across various therapy areas.
  2. 2. Table of contents:List of Tables 5List of Figures 6Glenmark Pharmaceuticals Ltd. Snapshot 7Glenmark Pharmaceuticals Ltd. Overview 7Key Information 7Key Facts 7Glenmark Pharmaceuticals Ltd. – Research and Development Overview 8Key Therapeutic Areas 8Glenmark Pharmaceuticals Ltd. – Pipeline Review 11Pipeline Products by Stage of Development 11Pipeline Products – Monotherapy 12Pipeline Products – Combination Treatment Modalities 13Glenmark Pharmaceuticals Ltd. – Pipeline Products Glance 14Glenmark Pharmaceuticals Ltd. – Late Stage Pipeline 14Phase III Products/Combination Treatment Modalities 14Glenmark Pharmaceuticals Ltd. Clinical Stage Pipeline Products 15Phase II Products/Combination Treatment Modalities 15Phase I Products/Combination Treatment Modalities 16Glenmark Pharmaceuticals Ltd. – Early Stage Pipeline Products 17Pre-Clinical Products/Combination Treatment Modalities 17Glenmark Pharmaceuticals Ltd. – Drug Profiles 18Flutican + Formoterol 18Product Description 18Mechanism of Action 18R&D Progress 18GBR 401 19Product Description 19Mechanism of Action 19R&D Progress 19GBR 600 20Product Description 20Mechanism of Action 20
  3. 3. R&D Progress 20GBR 900 21Product Description 21Mechanism of Action 21R&D Progress 21GRC 17536 22Product Description 22Mechanism of Action 22List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview – 2012&PubId=&pagenum=1Genta Incorporated – Product Pipeline Review – 2012Geron Corporation – Product Pipeline Review – 2012Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012iBio, Inc. – Product Pipeline Review – 2012ImmunoGen, Inc. – Product Pipeline Review – 2012
  4. 4. Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012Celtic Biotech, Ltd. – Product Pipeline Review – 2012Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012Endocyte, Inc. – Product Pipeline Review – 2012Flamel Technologies S.A. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: